Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-20
2000-12-12
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 11, 514 18, 514 19, 514 20, 514361, 514362, 514363, 514364, 514383, 530330, 530331, 530332, 548128, 548131, 548136, 548143, 5482668, 5482682, A61K 3805, A61K 3806, A61K 3807, A61K 3808
Patent
active
061599387
ABSTRACT:
Provided are methods of inhibiting the activity of a serine protease using protease inhibitors that include an alpha-keto heterocycle in their structure. The methods are useful in the treatment of ischemic heart or treatment of symptoms associated with blood coagulation disorders. Also provided are methods for detecting or quantifying the activity of a serine protease in a pure sample.
REFERENCES:
patent: 4338453 (1982-07-01), Gall
patent: 5055450 (1991-10-01), Edwards et al.
patent: 5164371 (1992-11-01), Edwards et al.
patent: 5550139 (1996-08-01), Groutas
patent: 5618792 (1997-04-01), Gyorkos et al.
patent: 5801148 (1998-09-01), Gyorkos et al.
patent: 5807829 (1998-09-01), Gyorkos
patent: 5861380 (1999-01-01), Gyorkos et al.
Skiles, J.W., et al. "Elastase Inhibitors Containing Conformationally Restricted Lactams as P.sub.3 -P.sub.2 Dipeptide Replacements," Bio. & Med. Chem. Ltrs. 3, 773-778 (1993).
Edwards, P. D., et al. "Peptidyl Alpha-Ketoheterocyclic Inhibitors of Human Neutrophil Elastase. 3. In Vitro and In Vivo Potency of a Series of Peptidyl Alpha-Ketobenzoxazoles," J. Med. Chem. 38, 3972-3982 (1995).
Edwards, P. D., et al. "Nonpeptic Inhibitors of Human Neutrophil Elastase. 7. Design, Synthesis, and in Vitro Acitivity of a Series of Pyridopyrimidine Trifluoromethyl Ketones," J. Med. Chem. 39, 1112-1124 (1996).
Edwards, P. D. et al. "Peptidyl Alpha-Ketoheterocyclic Inhibitors of Human Neutrophil Elastase. 2. Effect of Varying the Heterocyclic Ring on in Vitro Potency," J. Med Chem. 38, 76-85 (1995).
Veale, C. A., et al. "Non-peptidic Inhibitors of Human Leukocyte Elastase. 4. Design, Synthesis, and in Vitro and in Vivo Activity of a Series of Beta-Carbolinone-Containing Trifluoromethyl Ketones," J. Med. Chem. 38, 86-97 (1995).
Veale, C. A. et al. "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 5. Design, Synthesis, and X-ray Crystallography ofa Series of Orally Active 5-Aminopyrimidin-6-one-Containing Trifluoromethyl Ketones," J. Med. Chem. 38, 98-108 (1995).
Goddard, C. J., "Antiinflammatory 1-Phenylpyrazole-4-Heteroarylalkanoic Acids," J. Heterocyclics Chem., 28, 1607-1612 (1991).
LaMattina, J. L., et al. "Utility of 24 p-Nitrophenyl 3-Bromo-2,2-diethoxypropionate (NPBDP) in Heterocyclic Synthesis," J. Org. Chem. 49, 4800-4805 (1984).
Unangst, P.C., et al. "Novel 1,2,4-Oxadiazoles and 1,2,4-Thiadiazoles as Dual 5-Lipoxygenase and Cyclooxygenase Inhibitors," J. Med. Chem. 35, 3691-3698 (1992).
Kitatini, K., et al. "A Novel Oxazole Synthesis Utilizing Tungsten(VI) Catalyzed Decomposition of Alpha-Diazo Carbonyl Compounds in Nitriles," Tet. Lett. 16 1531-1532 (1974).
Wiley, R. H., "Chemistry of the Oxazoles," Chem. Rev. 37, 401-442 (1945).
Davidson, D., et al. "The Action of Ammonia of Bonzoin," J. Org. Chem. 2, 328-334 (1937).
Wiegand, Edwin E., et al. "Polyphosphoric Acid Cyclization of Acetamidoketones to 2,5-Dimethyl-1,3-oxazoles," Synthesis 12, 648-649 (1970).
Wasserman, H.H., et al. "The Oxazole-Triamide Rearrangement. Application To Peptide Synthesis," Tet. Lett. vol. 24, No. 37, 3831-3834 (1982).
Comforth, J. W., et al. "A New Synthesis of Oxazoles and Iminazoles including its Application to the Preparation of Oxazole." J. Chem. Soc. 96-102 (1947).
Comforth, J. W., "Synthesis of Oxazoles from Ethyl Acetoacetate. Ring-fisson of Some Oxazole-5-carboxylic Acids." J. Chem Soc. 93-98 (1953).
Bernstein, P. R., et al. "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 3. Design, Synthesis, X-Ray Crystallographic Analysis, and Structure--Activity Relationships for a Series of Orally Active 3-Amino-6-phenylpyridin-2-one Trifluoromethyl Ketones," J. Med. Chem. 37, 3313-3326 (1994).
Brown, F. J., et al. "Design of Orally Active, Non-Peptidic Inhibitors of Human Leukocyte Elastase," J. Med. Chem. 37, 1259-1261 (1994).
Warner, P., et al. "Non-peptidic Inhibitors of Human Leukocyte Elastase. 1. The Design and Synthesis of Pyridone-Containing Inhibitors," J. Med. Chem. 37, 3090-3099 (1994).
Budavari, Susan (Editor), "The Merck Index," An Encylopedia of Chemicals, Drugs, and Biologicals; Merck & Co., Inc., p. 294 (1989).
Damewood, J. R., et al. "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 2. Design, Synthesis, and in vitro Activity of a Series of 3-Amino-6-arylopyridin-2-one Trifluoromethyl Ketones," J. Med. Chem. 37, 3303-3312 (1994).
Cheronis John C.
Gyorkos Albert C.
Leimer Axel H.
Spruce Lyle W.
Cortech Inc.
Russel Jeffrey E.
LandOfFree
Serine protease inhibitors comprising .alpha.-keto heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease inhibitors comprising .alpha.-keto heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease inhibitors comprising .alpha.-keto heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-217070